Aurélien Delluc

The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Arthritis & Rheumatology · 2023 · 370 citations · Full text

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Annals of the Rheumatic Diseases · 2023 · 363 citations · Full text

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître et al. · Annals of the Rheumatic Diseases · 2012 · 199 citations

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

Benjamin Planquette, Laurent Bertoletti, Anaïs Charles‐Nelson et al. · CHEST Journal · 2021 · 142 citations

Thrombosis, Venous Thrombosis, Rivaroxaban Vs Dalteparin +10

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France

Aurélien Delluc, Cécile Tromeur, Florent Le Ven et al. · Thrombosis and Haemostasis · 2016 · 125 citations

Community-based Study, Logistic Analysis, Thrombosis +22